| Methods |
DESIGN: Randomised controlled trial
METHOD OF RANDOMISATION: Random stated. Method not described.
METHOD OF ALLOCATION CONCEALMENT: not stated.
OUTCOME ASSESSOR BLINDING: not stated.
WITHDRAWAL/DROPOUTS: all subjects accounted for. |
| Participants |
Eligible: not stated
Randomised: 62
Completed: 58 (Intervention 30, Control 28)
Age: mean: (Intervention 43.8, Control 43.8)
Range: Not specified
Sex: Male/Female ‐ not stated
Asthma diagnosis: not stated
Recruitment: not stated ‐ probably hospital outpatients department
Major exclusions: terminal care, cancer, AIDS or dementia.
Baseline:
FEV1 Not stated;
PEF Not stated
Exacerbations: Not stated |
| Interventions |
SETTING: Hospital and home
TYPE: Interactive
MODE: Individual and group sessions
Content: General aspects of the disease process, drug therapy, adverse effects, use of peak flow and inhaler technique |
| Outcomes |
Physician visits/ phone calls, hospitalisation, days off work or school, quality of life, rescue medication, steroid use, physician costs, medication costs, lost earnings |
| Notes |
|
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Adequate sequence generation? |
Unclear risk |
Described as randomised; other information not available |
| Allocation concealment? |
Unclear risk |
Information not available |
